ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 780

$1.17M Total Retail Price of All Prescriptions

Rank: 38 out of 780

624 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 624 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 18,833 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 680 568 S3 1 1
FUROSEMIDE 662 634 2 7
SIMVASTATIN 634 554 3 2
OMEPRAZOLE 541 482 4 3
LISINOPRIL 532 485 5 6
AMLODIPINE BESYLATE 517 497 6 4
LEVOTHYROXINE SODIUM 516 446 7 5
CITALOPRAM HBR 478 412 8 23
CARVEDILOL 448 387 9 14
DONEPEZIL HCL 441 431 10 31
TRAMADOL HCL 379 321 11 15
POTASSIUM CHLORIDE 368 329 12 11
TRAZODONE HCL 357 330 13 35
QUETIAPINE FUMARATE 327 299 14 81
CLOPIDOGREL 323 293 15 34
LANTUS 318 299 16 71
GABAPENTIN 310 290 17 13
LOSARTAN POTASSIUM 292 275 18 18
METOPROLOL TARTRATE 270 228 19 19
NAMENDA 233 226 20 46
RANITIDINE HCL 229 208 21 39
ISOSORBIDE MONONITRATE ER 222 209 22 60
PLAVIX 221 196 23 45
MELOXICAM 209 175 24 16
PANTOPRAZOLE SODIUM 209 200 24 25
HYDROCHLOROTHIAZIDE 193 172 26 10
ZOLPIDEM TARTRATE 189 161 27 17
SERTRALINE HCL 182 161 28 27
WARFARIN SODIUM 178 164 29 24
IPRATROPIUM-ALBUTEROL 163 154 30 214
SINGULAIR 156 131 31 73
MIRTAZAPINE 153 142 32 58
LYRICA 153 119 32 52
ATORVASTATIN CALCIUM 147 136 34 12
DIGOXIN 147 133 34 56
METFORMIN HCL 142 136 36 8
ATENOLOL 142 137 36 21
CYMBALTA 140 124 38 51
SPIRONOLACTONE 140 134 38 53
PRAVASTATIN SODIUM 140 111 38 9
CILOSTAZOL 139 123 41 229
AZITHROMYCIN 138 117 42 38
DIVALPROEX SODIUM 133 117 43 119
ROPINIROLE HCL 118 113 44 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 101 45 26
PREDNISONE 113 111 46 40
TAMSULOSIN HCL 113 107 46 36
SEROQUEL 112 105 48 172
HUMALOG 110 104 49 192
LEVOFLOXACIN 107 95 50 76
CIPROFLOXACIN HCL 105 97 51 49
PHENYTOIN SODIUM EXTENDED 102 81 52 128
DILTIAZEM 24HR CD 102 76 52 138
ALLOPURINOL 93 66 54 29
NOVOLOG 93 80 54 158
POLYETHYLENE GLYCOL 3350 93 61 54 79
METOCLOPRAMIDE HCL 93 85 54 102
CYCLOBENZAPRINE HCL 92 80 R 58 42
FLUTICASONE PROPIONATE 88 67 59 41
NEXIUM 87 59 60 22
EXELON 85 85 61 132
CELEBREX 85 65 61 89
LIDODERM 84 80 63 224
RISPERIDONE 83 83 64 98
MUPIROCIN 77 58 65 173
FAMOTIDINE 77 67 65 86
NITROFURANTOIN 77 76 65 235
MONTELUKAST SODIUM 77 62 65 120
METOPROLOL SUCCINATE 75 69 69 20
CARBIDOPA-LEVODOPA 72 72 70 124
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 62 71 88
PROMETHAZINE HCL 69 32 R 72 66
CLONIDINE HCL 67 58 73 28
LEVETIRACETAM 66 33 74 130
CRESTOR 64 50 75 32
SPIRIVA 63 63 76 72
HYDROXYZINE HCL 63 52 R 76 155
BUTORPHANOL TARTRATE 61 61 78 413
TRAVATAN Z 61 55 78 315
GLYBURIDE 60 56 R 80 101
JANUVIA 60 53 80 85
LEVOTHROID 60 53 80 416
KLOR-CON M20 58 55 83 57
AMIODARONE HCL 56 56 84 139
DIOVAN 55 38 85 55
METFORMIN HCL ER 54 52 86 43
METHADONE HCL 53 53 S2 87 127
FENTANYL 53 43 S2 87 107
BUSPIRONE HCL 53 53 87 125
MEGESTROL ACETATE 51 50 R 90 161
GEODON 51 46 90 342
GLIMEPIRIDE 50 45 92 30
ALENDRONATE SODIUM 50 49 92 44
TIZANIDINE HCL 50 41 92 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.